drugset / Trial / NCT02335359

Tranexamic Acid in Major Vascular Surgery

NCT02335359 ↗

Phase 4 Completed 100 enrolled IRCCS San Raffaele
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine whether tranexamic acid is effective in reducing intraoperative blood loss and necessity for haemotransfusion in patients undergoing open abdominal aortic aneurysm repair

Timeline

Start
2015-03-04
Primary completion
2017-10-30
Completion
2018-10-30

Outcome

Missed primary endpoint

paper Median (inter-quartile range) intraoperative blood loss was 400 (300-1050) ml in the tranexamic acid group vs 500 (360-1000) ml in the placebo group (P=0.44). PMID 31607387 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 250 mg Intravenous

Indications

No indication recorded.